Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Flammini

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Chemistry & Biodiversity|January 22, 2008
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptorMirko Rivara, Federica Vacondio, Claudia Silva, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2006
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffoldGiovanni Morini, Mara Comini, Mirko Rivara, et al.
Bioorganic & Medicinal Chemistry|November 4, 2008
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activityGiovanni Morini, Mara Comini, Mirko Rivara, et al.
International Journal of Pharmaceutics|October 5, 2025
Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditionsInês A Parente, Linda Chiara, Lisa Flammini, et al.
Current Cancer Drug Targets|February 1, 2023
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in MiceSilvia La Monica, Valentina Coccé, Mara Bonelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 6, 2017
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell linesSilvia La Monica, Daniele Cretella, Mara Bonelli, et al.
Frontiers in Pharmacology|July 13, 2019
Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBDAndrea Grandi, Irene Zini, Simone Palese, et al.
Medchemcomm|August 16, 2018
Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M<sub>1</sub> and M<sub>2</sub>Regina Messerer, Clelia Dallanoce, Carlo Matera, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 24, 2020
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in ratsEride Quarta, Veronica Chierici, Lisa Flammini, et al.
International Journal of Antimicrobial Agents|October 15, 2023
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosaStefania Glieca, Eride Quarta, Benedetta Bottari, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Chemistry & Biodiversity|January 22, 2008
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptorMirko Rivara, Federica Vacondio, Claudia Silva, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2006
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffoldGiovanni Morini, Mara Comini, Mirko Rivara, et al.
Bioorganic & Medicinal Chemistry|November 4, 2008
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activityGiovanni Morini, Mara Comini, Mirko Rivara, et al.
International Journal of Pharmaceutics|October 5, 2025
Functional and morphological characterisation of human colonoid-derived monolayers under inflammatory conditionsInês A Parente, Linda Chiara, Lisa Flammini, et al.
Current Cancer Drug Targets|February 1, 2023
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in MiceSilvia La Monica, Valentina Coccé, Mara Bonelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 6, 2017
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell linesSilvia La Monica, Daniele Cretella, Mara Bonelli, et al.
Frontiers in Pharmacology|July 13, 2019
Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBDAndrea Grandi, Irene Zini, Simone Palese, et al.
Medchemcomm|August 16, 2018
Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M<sub>1</sub> and M<sub>2</sub>Regina Messerer, Clelia Dallanoce, Carlo Matera, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 24, 2020
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in ratsEride Quarta, Veronica Chierici, Lisa Flammini, et al.
International Journal of Antimicrobial Agents|October 15, 2023
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosaStefania Glieca, Eride Quarta, Benedetta Bottari, et al.
Pageof 5